Dr. Gerald Evans is the Chair of the Division of Infectious Diseases and a Professor in the Departments of Medicine, Biomedical & Molecular Sciences, and Pathology & Molecular Medicine at Queen’s University. He is also an Attending Physician in Infectious Diseases and Internal Medicine at the Kingston Health Sciences Center (KHSC). Lastly, he is a Scientist with the Institute for Clinical Evaluative Sciences (ICES). Dr. Evans received his MD from the University of Ottawa School of Medicine and completed his training in Internal Medicine with residencies at the University of Toronto and Ottawa. He completed a fellowship in Infectious Diseases at the University of Calgary.
Dr. Evans is the past president of the Association of Medical Microbiology and Infectious Disease (AMMI) Canada. He is a member of the Ontario Anti-infective Review Panel, and former chair of the Guidelines Committee of AMMI Canada. He is past chair of the Committee to Evaluate Drugs of the Ontario Ministry of Health and Long-Term Care(MOH LTC), the Ministry’s expert advisory committee on optimal drug utilization for the province of Ontario. He is a Co-investigator with the Ontario Drug Policy Research Network. He also serves as a member of the Committee to Evaluate Drugs-Cancer Care Ontario Subcommittee and is Chair of the Working Group on Drugs for Rare Diseases for the MOH LTC. Dr. Evans routinely evaluates, diagnoses and treats individuals with Lyme disease in his role as Infectious Disease Consultant at KHSC and has published in the area of Lyme disease diagnostic testing.
Dr. Evans is a Co-Applicant on the grant and will assist in recruitment of individuals with Lyme disease for the national patient cohort/biobank, the clinical assessment and longitudinal follow up of persons diagnosed with Lyme disease and contribute towards the creation of knowledge resources to help health care professionals and the public better understand the risks, diagnosis and management of Lyme disease in Canada (Pillar 4).